プログラム委員会
-
Tatsuo Kurokawa, DIAFellow, PHD Director General
The Japan Biosimilar Association, Japan -
Junko Sato, PHD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Hironobu Saito, PHD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Yoshihiro Katsura, MS Regulatory Coordination Officer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Michelle Limoli, PHARMD, RPH Associate Director, International Programs
FDA, United States -
Masafumi Yokota, DVM, PHD Senior Director
Daiichi Sankyo Co., Ltd., Japan -
Emi Tomotake Regulatory Affairs
Otsuka Pharmaceutical Co., Ltd., Japan -
Yoshiaki Uyama, PHD, MS, RPH Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Satoshi Saeki, MSC Head of Japan Operational Excellence, Medical Affairs, Japan
Astellas Pharma Inc., Japan -
Rie Matsui, RPH Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan -
Joan Wilmarth Blair, MA Senior Advisor for International Affairs to the Director/Deputy Director, CBER
FDA, United States -
Sabine Luik EFPIA Member ICH Steering Committee, Sr Vice President Medicine & Regulatory
Boehringer Ingelheim Pharmaceuticals, United States
